3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
2
Solid Tumors
1
Polycystic Ovary Syndrome
1
Pediatric Brain Tumor
1
Lung Neoplasms
1
Inflammation
1
Hyperinsulinism
1
Heart Failure
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cardiotoxicity
1
Adenocarcinoma of Lung
1
Interventions
epigallocatechin gallate
2
Ascorbic Acid
2
semaglutide
1
microcrystalline cellulose
1
dapagliflozin
1
cytisine
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
XENP 1595
1
Vitamin D
1
Topiramate
1
Tirzepatide
1
Spirometry
1
Selenium
1
Saline Solution
1
Resistance Training
1
Reperfusion
1
Qsymia
1
Probiotics
1
Platelet Count
1
Plastic Surgery Procedures
1
Phentermine
1
Naltrexone
1
Losartan
1
Liraglutide
1
Ischemic Preconditioning
1
Hematologic Tests
1
Glucagon-Like Peptide-1 Receptor
1
Endurance Training
1
Diethylpropion
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
dapagliflozin
×
1 year
×
Clear all
NCT07245069
2025-11-24
Alpaca
University Medical Centre Ljubljana
Phase 2
Recruiting
100 enrolled